An in-vivo―in-vitro correlation for the bioavailability of frusemide tabletsKINGSFORD, M; EGGERS, N. J; SOTEROS, G et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 8, pp 536-538, issn 0022-3573Article

Addressing Bioavailability & DigestibilityMERMELSTEIN, Neil H.Food technology (Chicago). 2011, Vol 65, Num 3, pp 76-79, issn 0015-6639, 4 p.Article

Bioavailability of phenolic compoundsKARAKAYA, Sibel.Critical reviews in food science and nutrition. 2004, Vol 44, Num 6, pp 453-464, issn 1040-8398, 12 p.Article

Effect of Inorganic and Organic Ligands on the Bioavailability of Methylmercury as Determined by Using a mer-lux BioreporterNDU, Udonna; MASON, Robert P; HUAN ZHANG et al.Applied and environmental microbiology (Print). 2012, Vol 78, Num 20, pp 7276-7282, issn 0099-2240, 7 p.Article

La biodisponibilitéCARON, J; LACROIX, D; LIBERSA, C et al.NPN médecine. 1991, Num 179, pp 524-526, issn 0248-9635Article

Oral bioavailability of flutamide from 1-O-alkylglycerol stabilized o/w nanoemulsionsMADHUSUDHAN, B; RAMBHAU, D; APTE, S. S et al.Journal of dispersion science and technology. 2007, Vol 28, Num 8, pp 1254-1261, issn 0193-2691, 8 p.Article

Increasing bioavailability of iron-fortified foodsTURNER, Elizabeth; BAGRIANSKY, Jack.Food technology (Chicago). 2005, Vol 59, Num 8, pp 74-78, issn 0015-6639, 4 p.Article

Pharmacocinétique: principes fondamentaux = Pharmacokinetics: main principlesLABAUNE, J. P; WEPIERRE, J.1984, 426 p., isbn 2-225-80136-3Book

Nanotechnology for increased micronutrient bioavailabilityJOYE, Iris J; DAVIDOV-PARDO, Gabriel; MCCLEMENTS, David Julian et al.Trends in food science & technology (Regular ed.). 2014, Vol 40, Num 2, pp 168-182, issn 0924-2244, 15 p.Article

Pharmacokinetics and bioavailability of the anti-emetic agent bromoprideBRODIE, R. R; CHASSEAUD, L. F; DARRAGH, A et al.Biopharmaceutics & drug disposition. 1986, Vol 7, Num 3, pp 215-222, issn 0142-2782Article

Circadian changes in carrageenin-induced edema: the anti-inflammatory effect and bioavailability of phenylbutazone in ratsLOUBARIS, N; MICHEL, A; CROS, G et al.Life sciences (1973). 1984, Vol 34, Num 24, pp 2379-2384, issn 0024-3205Article

Enhanced absorption of phenobarbital from suppositories containing phenobarbital povidone coprecipitateIWAOKU, R; OKAMATSU, Y; KINO, S et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 3, pp 1091-1095, issn 0009-2363Conference Paper

Product Design: A Nanomized Nutraceutical with Enhanced Bioactivity and BioavailabilityTIN LAU, Yeuk; NA CHEN; MING KO, Kam et al.Industrial & engineering chemistry research. 2012, Vol 51, Num 21, pp 7320-7326, issn 0888-5885, 7 p.Article

Bioavailability of non-nutrients for preventing lifestyle-related diseases : RECENT DEVELOPMENTS IN FOOD SCIENCE AND TECHNOLOGY IN JAPANKANAZAWA, Kazuki.Trends in food science & technology (Regular ed.). 2011, Vol 22, Num 12, pp 655-659, issn 0924-2244, 5 p.Article

Micronutrient bioavailability research prioritiesCASGRAIN, Amelie; COLLINGS, Rachel; HARVEY, Linda J et al.The American journal of clinical nutrition. 2010, Vol 91, Num 5, issn 0002-9165, 1423S-1429SConference Paper

Novel method of calculating absolute bioavailability in nonlinear pharmacokineticsVENG-PEDERSEN, P.Journal of pharmaceutical sciences. 1985, Vol 74, Num 1, pp 90-93, issn 0022-3549Article

Evaluation of the bioavailability of sarpicillin, the methoxymethyl ester of hetacillin, in humansSTAVCHANSKY, S; PEARLMAN, R. S; VAN HARKEN, D. R et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 2, pp 169-173, issn 0022-3549Article

Chemodynamics and Bioavailability in Natural WatersBUFFLE, Jacques; WILKINSON, Kevin J; VAN LEEUWEN, Herman P et al.Environmental science & technology. 2009, Vol 43, Num 19, pp 7170-7174, issn 0013-936X, 5 p.Article

Verfügbarkeitsprüfung in vitro: Forderungen, Möglichkeiten, Grenzen = Tests in vitro de disponibilité: exigences, possibilités, limites = In vitro tests for availability: requirements, possibilities, boundsDIBBERN, H.-W.Pharmazeutische Industrie. 1984, Vol 46, Num 4, pp 381-385, issn 0031-711XArticle

Cimetidine bioavailability and variable renal clearanceGRAHNEN, A.European journal of clinical pharmacology. 1984, Vol 27, Num 5, pp 623-624, issn 0031-6970Article

Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studiesLAUFFER, R. B; GREIF, W. L; STARK, D. D et al.Journal of computer assisted tomography. 1985, Vol 9, Num 3, pp 431-438, issn 0363-8715Article

Möglichkeiten zur in-vitro-Beurteilung der Bioverfügbarkeit. IV: Vergleich der Carbamazepinpräparate Finlepsin® und Tegretol® = Evaluation de la biodisponibilité in vitro. IV: comparaison de 2 formes de carbamazépine Finlepsin^® et Tegretol^® = Possibilities of the in vitro evaluation of bioavaibility. IV: comparison of carbamazepine preparations Finlepsin^® and Tegretol^®FÜRST, W; NEUBERT, R; BUCHMANN, E et al.Pharmazie. 1984, Vol 39, Num 3, pp 185-186, issn 0031-7144Article

Correlation between the bioavailability of microencapsulated bacampicillin hydrochloride in suspension and in vitro microcapsule dissolutionSJOVALL, J; SJOQVIST, R; HUITFELDT, B et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 2, pp 141-145, issn 0022-3549Article

Rapid quantitative liquid chromatographic determination of caffeine levels in plasma after oral dosingÓCONNELL, S. E; ZURZOLA, F. J.Journal of pharmaceutical sciences. 1984, Vol 73, Num 7, pp 1009-1011, issn 0022-3549Article

Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpineSAETTONE, M. F; GIANNACCINI, B; CHETONI, P et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 4, pp 229-234, issn 0022-3573Article